Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ZSY
|
|||
| Former ID |
DNC002842
|
|||
| Drug Name |
Nitrilotriacetic Acid
|
|||
| Synonyms |
NITRILOTRIACETIC ACID; 139-13-9; 2,2',2''-nitrilotriacetic acid; Triglycollamic acid; Aminotriacetic acid; Nitrilotriacetate; Complexon I; Trilon A; N,N-Bis(carboxymethyl)glycine; Titriplex I; Komplexon I; NTA; Versene NTA acid; Nitrilotriessigsaeure; Hampshire NTA acid; Nitriloacetate; 2-[bis(carboxymethyl)amino]acetic acid; Glycine, N,N-bis(carboxymethyl)-; Tri(carboxymethyl)amine; Tris(carboxymethyl)amine; Acetic acid, nitrilotri-; CHEL 300; NCI-C02766; Nitrilo-2,2',2''-triacetic acid; Nitrilotriacetic acid (NTA); CCRIS 436
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H9NO6
|
|||
| Canonical SMILES |
C(C(=O)O)N(CC(=O)O)CC(=O)O
|
|||
| InChI |
1S/C6H9NO6/c8-4(9)1-7(2-5(10)11)3-6(12)13/h1-3H2,(H,8,9)(H,10,11)(H,12,13)
|
|||
| InChIKey |
MGFYIUFZLHCRTH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 139-13-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
68808, 608122, 827551, 3141327, 3293308, 5263077, 7889490, 8010124, 8139938, 8156207, 10507544, 15322255, 17389804, 17395694, 24861313, 24864721, 24886420, 24886421, 24897916, 26697146, 26752915, 29227411, 46504710, 48414110, 48423845, 48425396, 49854983, 51075352, 57325223, 57649238, 57652424, 57652425, 58023900, 79009449, 85088158, 85088160, 87573489, 88835500, 92251279, 93165813, 96107380, 104250999, 104318679, 117610991, 118233040, 121281654, 123071421, 124600051, 124800223, 124890500
|
|||
| ChEBI ID |
CHEBI:44557
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lactotransferrin (LTF) | Target Info | Inhibitor | [1] |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| TCR Signaling Pathway | ||||
| Reactome | ROS production in response to bacteria | |||
| Amyloid formation | ||||
| WikiPathways | Latent infection of Homo sapiens with Mycobacterium tuberculosis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.